Crohn's disease and ulcerative colitis, the two main types of inflammatory bowel disease (IBD), were reported to be associated with a variety of genetic polymorphisms. A subset of these polymorphisms was identified in both diseases and only three of them were found in primary sclerosing cholangitis (PSC). rs3197999 (Arg689Cys) located in the MST1 gene is one of the most convincingly replicated IBD/PSC-associated polymorphisms but its functional consequences have not been investigated, yet. We expressed both MST1 gene variants (Arg 689 (MSP wt ) and Cys 689 (MSP mut )) in a eukaryotic cell system and compared their stimulatory effects on macrophage-like THP-1 cells. Except for the rate of apoptosis that remained unchanged, MSP mut significantly increased the stimulatory effect of MSP (macrophage-stimulating protein) on chemotaxis and proliferation by THP-1 cells, indicating a gain of function associated with the Arg689Cys exchange. A broad set of evidence reported previously suggests that pro-inflammatory changes in macrophage function have a major role in the initiation of the inflammatory process in IBD and PSC. Therefore, the gain of function observed with rs3197999 in MST1 might provide a cellular mechanism for the consistent association of this polymorphism with an increased risk for IBD and PSC.
INTRODUCTION
Crohn's disease (CD) and ulcerative colitis (UC), the two main types of inflammatory bowel disease (IBD), are both based on a chronically dysregulated mucosal homeostasis of the gut. The precise etiology remains unknown but environmental changes, genetic predisposition, gut microbial flora and mucosal immune activation contribute to the pathogenesis.
1,2 GWAS (genome-wide association studies) revealed B100 loci that are significantly associated with CD, UC or both. 3, 4 The diversity of the identified loci reflects the multifactorial pathogenesis of IBD but potentially affected physiological pathways cluster to innate and acquired immunity and intestinal epithelial defense.
The lamina propria of the gut epithelium contains the largest pool of macrophages in the body that are predominantly recruited from the blood. On the one hand, these macrophages are exposed to a vast amount of bacteria and antigenic stimuli, mostly benign commensals and food components that should not induce any inflammatory response. On the other hand, macrophages represent the first line of defense against harmful pathogens; the recognition of conserved structures of infectious agents triggers a rapid response. Moreover, macrophages, along with dendritic cells, presenting antigens to lymphocytes instigate the response of the more flexible, but slower adaptive immune system. In UC as well as in CD, excessive activation of innate immunity seems to initiate inflammation and to be a prerequisite for the activation of the adaptive immune system. 2, 5 In 2.4% of all patients, IBD is accompanied by primary sclerosing cholangitis (PSC), a chronic inflammatory and cholestatic liver disease, 6 which is, inter alia, characterized by the accumulation of macrophages in sinusoidal and perisinusoidal spaces. 7 In all, 75 --90% of PSC patients have a history of or a co-existing IBD. For that matter PSC is not dependent on an active intestinal disease but may also occur in patients with preceding colectomy indicating common pathogenetic factors in IBD and PSC. In parallel to IBD, PSC is thought to be set off by an activation of the innate immune system, possibly triggered by bacteria or pathogen-associated molecular patterns delivered to the liver by the portal vein. A common genetic basis of IBD and PSC has been hypothesized, but merely for three of the analyzed susceptibility genes significant associations with both IBD and PSC have been demonstrated to date. 8 One of the loci reported to be associated with IBD and PSC by several GWAS (odds ratio B1.22 in IBD and B1.4 in PSC), 3,4,9 --15 is rs3197999 (c.2078C4T; minor allele frequency 0.297), a common polymorphism in the MST1 (macrophage stimulating 1) gene, resulting in the substitution of an arginine by a cysteine at position 689 of MSP (macrophage-stimulating protein; synonym: HGF (hepatocyte-growth factor) like protein). Arg 689 is one out of five arginine residues suggested to be essential for the binding of MSP to its receptor RON (recepteur d'origine nantais). 16 MSP belongs to the plasminogen-related kringle domain family. It is a 78-kDa serum protein consisting of two disulfide-linked polypeptide chains and displays a 45% sequence homology to HGF. 17 MSP is mainly expressed in the liver from where it is released into the circulating blood as a biologically inactive pro-protein. 18 Pro-MSP is activated according to the local requirements by trypsin-like proteases such as kallikrein. 19 Unlike most proteins of the plasminogen-related family that are serine proteases, both MSP and HGF are enzymatically inactive, 17, 20, 21 but regulate growth and motility. Binding of MSP to RON sets off multiple signal cascades affecting cell motility, proliferation, adhesion, apoptosis/ anoikis and cytokine secretion. RON is expressed in several tissues, such as bone marrow, 22 lung, colon and skin, and other cells of epithelial origin. 23, 24 In macrophages, RON expression is restricted to tissue macrophages 25 --28 and monocytes adhering to the vessel endothelium. 22 RON is not expressed in peripheral blood monocytes, neutrophils or lymphocytes. 25 To date, it is still unknown whether rs3197999 itself or a genetic variation in linkage disequilibrium with rs3197999 is responsible for its consistently reported association with IBD. 4 Potential functional consequences of Arg689Cys in MSP that might explain this association have not been investigated, yet. Therefore, we expressed human wild-type (wt; Arg
689
) and mutant-type (mut; Cys 689 ) MSP in a eukaryotic cell system and evaluated these recombinant proteins with respect to functional differences in cell culture. In order to rule out cell proliferation as a major cause of the observed differences in migration induced by MSP wt and MSP mut , cells of both chambers were counted at the end point of the experiment and compared with the initial cell count: The total cell count remained largely constant in the course of the experiment (cell count at the end point: 80 --100% of the initial cell count) pointing to a marginal impact of proliferation in this experimental setting most likely due to the presence of the chemoattractant EAMS.
RESULTS

Analysis of MSP clones
MSP-induced proliferation in macrophage-like THP-1 cells The MSP-activated proliferation rate of macrophage-like THP-1 cells was determined by the assessment of 5-bromo-2 0 -deoxyuridine (BrdU) incorporation into newly synthesized DNA. As specified for the Boyden chamber experiments, cell culture medium and supernatant of non-transfected CHO-K1 cells served as negative controls. Again the negative control values were subtracted from the MSP-stimulated proliferation rates. MSP concentration-dependent proliferation curves clearly demonstrate that MSP mut is more effective than MSP wt ( Figure 3a ): Figure 3b shows BrdU incorporation at the MSP concentrations inducing the most striking differences between MSP wt and MSP mut The maximum difference was observed at a concentration of 0.5 ng ml induced apoptosis. Supernatant of non-transfected CHO-K1 cells was used as negative control. Staurosporine-induced apoptosis is shown in Figure 5 and revealed the functionality of the caspase 3 and 7 activity assay.
DISCUSSION GWAS are undertaken in order to identify genes contributing to the genetic backgrounds of complex, multifactorial diseases and to generate hypotheses concerning disease pathogenesis. IBD was reported to be associated with a variety of SNPs (single-nucleotide polymorphisms). 3,4,9 --11,15,30 Some of these SNPs were useful in defining IBD-associated genes, which were then traced to several pathways including microbe recognition and autophagy by macrophages, interleukin (IL) signaling and lymphocyte activation, survival and growth. 3 Only one gene, namely NOD2 (nucleotidebinding oligomerization domain protein 2), contributes substantially to the risk of CD (20-fold risk in homozygous carriers 31 --33 ). Most other SNPs reported to date increase disease risk to a much lesser extent (odds ratio o1.5) but might be valuable in elucidating IBD pathophysiology. For the bulk of identified SNPs, however, their respective pathophysiological significance remains unclear and in many cases, the IBD-associated genes have not been identified unequivocally, yet. rs3197999 in the MST1 gene, one of the most convincingly replicated IBD-associated polymorphisms 4,9 --12,15,30 causes the exchange of an amino acid conserved across species and predicted to alter protein structure and/or function (prediction tools: sorting tolerant from intolerant (SIFT) algorithm (http://sift.jcvi.org), Polymorphism Phenotyping v2.1.0 (http://genetics.bwh.harvard.edu/pph2/index.shtml). We expressed the MST1 gene in a eukaryotic cell system and we were able to demonstrate a significantly enhanced activity of the mut MSP protein (Cys 689 ): MSP mut -induced migration and proliferation in macrophage-like THP-1 cells more effectively than MSP wt (Figures 2 and 3) . A broad set of evidence, detailed below, suggests that this spectrum of macrophage functions play a major role in IBD and also PSC pathogenesis, strongly arguing for MST1 as the disease-associated gene within region 3p21 and for rs3197999 as the association-causing genetic variant.
Macrophages are essential in the rapid response to bacteria and other pathogens. They initiate the recruitment of cells of the adaptive immunity. In the gut epithelium, a large amount of resident macrophages meets with a mass of luminal bacteria, which does not induce inflammation in healthy individuals. Mucosal macrophages originate from CD14 þ blood monocytes expressing surface molecules facilitating the adhesion of monocytes especially to sites of infection and inflammation but also to unaffected mucosa. 34 --36 In the environment of a non-inflamed mucosa, recruited macrophage precursor cells lose their ability to migrate towards chemoattractants, to proliferate, to secrete cytokines and to respond by respiratory burst. Instead, they intensify their bactericidal activity and their phagocytic activity of inert material. Thus, resident intestinal macrophages scavenge cell debris and harmless microorganisms without inducing any inflammatory response. However, macrophages of an inflammatory phenotype, as observed in infectious diseases and IBD for instance, conserve the properties of the precursor cells in many respects. In UC as well as in CD, excessive activation of the innate immunity initiates the inflammatory process, which is a prerequisite of the activation of the adaptive immune system, the latter being the main cause of tissue damage in IBD. 2, 5 A similar mechanism is postulated in PSC except that Kupffer cells are not directly exposed to luminal gut microbes but to bacterial and pathogenic material from the portal vein. rs3197999 is one of the few SNPs associated with three different disease entities, UC, CD and PSC, which although distinct from each other share a common macrophage-dependent initiation mechanism. Whereas RON is not expressed in monocytes of the circulating blood, its expression could be demonstrated in macrophage precursor cells adhering to the vessel wall. 34, 35, 37 At this early stage of macrophage recruitment, the presence of MSP mut may impair the differentiation into resident intestinal macrophages but instead promote an inflammatory phenotype. This hypothesis is supported by the fact that MSP mut enhances a certain spectrum of macrophage functions, which is characteristic of the inflammatory phenotype of macrophages.
A hyperinflammatory immune response of mononuclear cells similar to that induced by MSP mut is known to cause enterocolitis as illustrated by the following examples: 1. The rare, homozygous IL-10 receptor defect prevents the IL-10-mediated inhibition of pro-inflammatory cytokine release and results in severe, early-onset IBD. 38 2. Polymorphisms located in genes of the IL-23 pathway (for example, IL-23R; JAK2, STAT3) were shown to be associated with both, UC and CD, with the minor allele being protective against IBD. 3, 39 In resident peritoneal macrophages stimulated by LPS (lipopolysaccharide) and IFN-g, MSP was reported to suppress IL-12/IL-23 p40 and TNF-a release independent from IL-10. 40 Deficient down-regulation of IL-12/IL-23 release by macrophages of the inflammatory phenotype induces T-helper cell differentiation (Th1, Th17) and/or stabilization of the differentiation status, 41 which is essential for the activation of the adaptive immune response in IBD. 3. Furthermore, monoclonal antibodies targeting the p40 subunit of IL-12 and IL-23 were effective in treating patients with CD in preliminary studies. 42 We conclude that MST1 is the most likely IBD/PSC-associated gene defined by the rs3197999 association and rs3197999 itself is the genetic variant causing disease association. The gain of function caused by rs3197999 has at least two effects, which would be expected to promote local inflammation: (1) increased attraction of macrophages to chemotactic agents and (2) increased macrophage proliferation.
MATERIALS AND METHODS
Reagents and antibodies
Recombinant human IFN-g and TNF-a, mouse serum and all cell culture reagents were obtained from Invitrogen (Carlsbad, CA, USA). LPS from Escherichia coli serotype 0111:B4, LPS from Samonella typhi, and staurosporine were purchased from Sigma (St Louis, MO, USA). Human recombinant kallikrein was obtained from Enzyme Research Laboratories Ltd. (Swansea, UK). Anti-human MSP antibody was purchased from R&D Systems (Minneapolis, MN, USA), anti-human RON antibody from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-goat IgG and anti-rabbit IgG antibodies conjugated with HRP were obtained from Jackson (Suffolk, UK).
Cell culture CHO-K1 cells were obtained from the ECACC (Salsbury, UK). Cells were grown in F12 medium supplemented with 10% fetal bovine serum (FBS) and 2 mM glutamine.
HepG2 cells and THP-1 (acute monocytic leukemia) cells were purchased from the DSMZ (Braunschweig, Germany) and the latter were maintained in RPMI 1640 medium supplemented with 10% FBS, 1 mM sodium pyruvate and 2 mM glutamine. HepG2 cells were cultured in RPMI 1640 medium supplemented with 10% FBS. The cell lines were cultured in a 37 1C humidified atmosphere containing 5% CO 2 . For all subsequent experiments, THP-1 cells were pre-stimulated by IFN-g (400 U ml
) and TNF-a (10 ng ml À 1 ) in RPMI 1640 medium containing 10% FBS, 2 mM glutamine und 1 mM sodium pyruvate for 24 h. The assays were performed in RPMI 1640 medium containing 1% FBS.
Preparation of EAMS
Mouse serum was incubated with S. typhi LPS (10 mg ml Expression of human MSP in CHO-K1 cells CHO-K1 cells, a well-established system for the expression of human MSP, 43, 44 were transfected with the eukaryotic expression vector pcDNA3.1/V5-His, containing wt or mut MSP cDNA using FuGENE HD Transfection Reagent (Roche, Mannheim, Germany) and transfected cells were selected in 1 mg ml --1 G418 (Roth, Karlsruhe, Germany). Individual clones were obtained by limiting dilution. Expression of human MSP mRNA was checked by conventional PCR using the following primers: forward primer (sequence located in expression vector): 5 0 -ATAGGGAGACC CAAGCTGGCTAGT-3 0 ; reverse primer (sequence located in MSP transcript): 5 0 -GGCCGCACGTCGTCTGTA-3 0 . The primer design ensured the amplification of human recombinant MSP.
The supernatant of transfected and non-transfected CHO-K1 cells (grown in RPMI 1640 supplemented with 1% FBS, without G418) was harvested. MSP concentrations were quantified by ELISA according to the manufacturer's instructions (R&D Systems). Pro-MSP was activated by kallikrein digestion for 30 min at 37 1C with 30 mg kallikrein ml 
Western blot analysis
Equal amounts of pro-MSP and kallikrein-digested MSP in CHO-K1 lysates and supernatants were resolved by 10% SDS --PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) and examined by standard western blotting procedures. Anti-human MSP antibody was used at a 1:1500 dilution, anti-goat IgG was diluted 1:10 000. RON expression was analyzed in THP-1 cells before and after induction of differentiation by SDS --PAGE and western blotting. Anti-human RON antibody was used at a 1:500 dilution, anti-rabbit IgG was diluted 1:10 000. 
RON and GILT-PCR
Staining of THP-1 cells
The morphological properties of differentiated THP-1 cells were determined by Wright-Giemsa staining of cytospin preparations.
Macrophage chemotaxis assay
A total of 50 000 THP-1 cells in 100 ml were added to the upper chamber of a transwell filter insert (24-well plates, 5 mm pore size; Corning B.V. Life Sciences, Amsterdam, The Netherlands) containing CHO-K1 supernatant with different concentrations of MSP wt /MSP mut . The medium in the bottom well contained 10 ml ml --1 EAMS as a chemoattractant. After 24 h, the medium of the lower chamber was collected and the number of migrated cells per well was determined by cell counting in a hemocytometer or by measuring ATP concentrations (Kinase-Glo Luminescent Kinase Assay; Promega Corp., Madison, WI, USA).
Macrophage proliferation assay
The cell proliferation rate was determined using a cell proliferation ELISA (Roche) via BrdU incorporation into newly synthesized DNA according to the manufacturer's protocol.
BrdU was added to a total of 50 000 THP-1 cells in 100 ml medium containing CHO-K1 supernatant with MSP wt /MSP mut . Cells were incubated for 24 h in a 96-well microplate. Subsequently, the plates were centrifuged at 450 g for 10 min and the medium was removed. The cells were dried at 60 1C for 1 h and then treated as described in the manufacturer's instructions.
Analysis of apoptosis MSP-dependent programmed cell death was analyzed by determining caspase 3 and 7 activity and by quantifying the degree of DNA fragmentation:
A total of 25 000 THP-1 cells in 50 ml medium containing CHO-K1 supernatant with MSP wt /MSP mut or supernatant of non-transfected cells were incubated for 1, 2 and 4 h in a 96-well microplate. Caspase 3 and 7 activities were determined using Caspase-Glo 3/7 assay according to the manufacturer's instructions (Promega Corp.). As control, apoptosis was induced by different concentrations of staurosporine.
Alternatively TUNEL staining was performed. THP-1 cells were pretreated for 24 h with IFN-g (400 U ml À 1 ) and TNF-a (10 ng ml À 1 ) in eightwell Lab-Tek chamber slides (Nunc, Roskilde, Denmark) and incubated with different concentrations of kallikrein-activated and non-activated MSP wt / MSP mut or supernatant of non-transfected cells for 24 h. DNA fragmentation was examined in situ by the TUNEL method using the In situ Cell Death Detection Kit (Roche) according to the manufacturer's instructions. As a negative control, cells were incubated with all assay reagents omitting the labeling enzyme. As a positive control, cells were pre-treated with 600 U ml 
Statistics
MedCalc 4 (Mariakerke, Belgium) was used to perform all statistical analyses. Comparisons between the two groups were performed by paired two-tailed or one-tailed t-test. P-values p0.05 were considered significant.
